Williams D A
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Hematol Oncol Clin North Am. 1988 Jun;2(2):277-87.
Since initial reports of gene transfer into hematopoietic stem cells 4 years ago, progress has been made in both the methodology of gene transfer and the design of vectors. However, substantial problems remain before serious considerations of attempting gene transfer in humans can be made. The efficient transfer of genes into very primitive stem cells capable of long-term repopulation of larger species is a crucial problem. In addition, high level and sustained expression in vivo remains a problem for most transferred sequences. Given the current level of research in the areas of retrovirus vectors and eukaryotic gene regulation, these problems are likely to be resolved in the future.
自从4年前首次报道将基因转移到造血干细胞以来,基因转移方法和载体设计都取得了进展。然而,在认真考虑尝试在人类中进行基因转移之前,仍然存在重大问题。将基因高效转移到能够长期重建大型物种的非常原始的干细胞中是一个关键问题。此外,对于大多数转移序列来说,在体内高水平和持续表达仍然是一个问题。鉴于目前在逆转录病毒载体和真核基因调控领域的研究水平,这些问题在未来有可能得到解决。